there's an app for that

New app gives Houston hospital a better shot at giving COVID-19 vaccinations to employees

This Houston hospital is tapping into tech to best optimize its COVID-19 vaccination process. Photo courtesy of MD Anderson

Across the country, millions of people eagerly await their COVID-19 vaccinations. But many of them are encountering a big roadblock on the path toward eradicating the pandemic: scheduling their shots.

To overcome that hurdle, some organizations have turned to technology. San Antonio-based grocery chain H-E-B, for instance, will let customers schedule COVID-19 vaccinations through a web-based scheduler. As with H-E-B's app, many vaccination-scheduling tools are just now becoming available.

Houston's MD Anderson Cancer Center is one huge step ahead of the vaccination curve, though. Back in September, the hospital — part of the massive Texas Medical Center complex — started planning how it would roll out vaccinations for its more than 21,000-member workforce. As part of that planning, MD Anderson developed an in-house app enabling its employees to schedule their own vaccination appointments.

"We have an incredible team of informatics developers who worked in conjunction with our human resource and employee health leaders to design an app that's accessible on your phone or from any computer," says Dr. Welela Tereffe, chief medical executive at MD Anderson. "The app feeds you information about what appointments are available and then floats an appointment reminder to your calendar as well as sending you text reminders."

Beginning December 15, MD Anderson employees received the hospital's initial round of shots. They were the first employees who used the app to schedule appointments at workplace vaccination clinics. As of January 5, more than 8,700 hospital employees had been vaccinated with the first dose of either the Pfizer vaccine or Moderna vaccine. The immunizations are not mandatory. In all, 10,700 doses of COVID-19 vaccine have been shipped to MD Anderson since December 14, and every one of them is already spoken for.

Yolan Campbell, associate vice president of HR operations at MD Anderson, says the vaccination scheduling app built on knowledge the hospital's team had accumulated throughout 2020 in producing apps for COVID-19 tests and other pandemic-related purposes.

Tereffe notes that COVID-19 vaccination scheduling has "caused a lot of stress" for health care providers. MD Anderson hoped to avoid that stress by incorporating the app into its vaccination plan.

"The app that that our teams have designed is very simple, very user-friendly," Tereffe says. "It prompts you to put in your preferred contact information, both email and phone. It allows you to choose a block of time and a day that you'd like to be vaccinated. And it puts the information right there at your fingertips about the vaccine and the vaccine clinic process so that you can review it in real time."

As soon as an employee chooses an appointment slot, they receive conformation via the app. Through the app, an employee can cancel or reschedule an appointment.

"I think that level of access and control really helps to reassure people that they can trust the process," Tereffe said.

The app also gives MD Anderson more control over the vaccination clinics, according to Campbell and Tereffe. For instance, a dashboard created by IT professionals at the hospital gathers data from the app to track how many vaccinations have been given, how many appointments have been canceled, and which times and days are most popular for vaccinations. Tereffe said those real-time insights have enabled MD Anderson to adjust the operating hours for vaccination clinics.

To supplement the app, MD Anderson provides extra assistance with vaccination scheduling for employees with language or technology barriers, Tereffe said. The hospital also runs a vaccination hotline staffed by HR professionals.

Looking ahead, Tereffe said MD Anderson will accept any COVID-19 vaccine that's been approved by the U.S. Food and Drug Administration (FDA). So far, that's limited to the Pfizer and Moderna versions.

"We have a process in place to hold unique clinics for each type of vaccine and each dose of vaccine to ensure that people get the vaccine that they have chosen … and that they always get the correct second dose," Tereffe said. "Our intent is to help our employees make informed decisions."

Trending News

Building Houston

 
 

Dr. Peter Hotez and Dr. Maria Elena Bottazzi have been recognized by Fast Company for their leadership in developing low-cost COVID vaccine. Photo courtesy of Texas Children's

This week, Fast Company announced its 14th annual list of Most Creative People in Business — and two notable Houstonians made the cut.

Dr. Peter Hotez and his fellow dean of the National School of Tropical Medicine at Baylor College of Medicine, Dr. Maria Elena Bottazzi, were named among the list for “open sourcing a COVID-19 Vaccine for the rest of the world.” The list, which recognizes individuals making a cultural impact via bold achievements in their field, is made up of influential leaders in business.

Hotez and Bottazzi are also co-directors for the Texas Children's Hospital's Center for Vaccine Development -one of the most cutting-edge vaccine development centers in the world. For the past two decades it has acquired an international reputation as a non-profit Product Development Partnership (PDP), advancing vaccines for poverty-related neglected tropical diseases (NTDs) and emerging infectious diseases of pandemic importance. One of their most notable achievements is the development of a vaccine technology leading to CORBEVAX, a traditional, recombinant protein-based COVID-19 vaccine.

"It's an honor to be recognized not only for our team's scientific efforts to develop and test low cost-effective vaccines for global health, but also for innovation in sustainable financing that goes beyond the traditional pharma business model," says Hotez in a statement.

The technology was created and engineered by Texas Children's Center for Vaccine Development specifically to combat the worldwide problem of vaccine access and availability. Biological E Limited (BE) developed, produced and tested CORBEVAX in India where over 60 million children have been vaccinated so far.

Earlier this year, the doctors were nominated for the 2022 Nobel Peace Prize for their research and vaccine development of the vaccine. Its low cost, ease of production and distribution, safety, and acceptance make it well suited for addressing global vaccine inequity.

"We appreciate the recognition of our efforts to begin the long road to 'decolonize' the vaccine development ecosystem and make it more equitable. We hope that CORBEVAX becomes one of a pipeline of new vaccines developed against many neglected and emerging infections that adversely affect global public health," says Bottazzi in the news release from Texas Children's.

Fast Company editors and writers research candidates for the list throughout the year, scouting every business sector, including technology, medicine, engineering, marketing, entertainment, design, and social good. You can see the complete list here

.

Trending News